Hybrid closed-loop insulin therapy has shown promise for management of type 1 diabetes during pregnancy; however, its efficacy is unclear. In this multicenter, controlled trial, we randomly assigned ...

A wearable device pairs glucose-responsive insulin with algorithmic pump control, creating dual safety loops that reduced hypoglycemia from 4.01% to 0.52% in diabetic rats. (Nanowerk Spotlight) An ...